Almac to Speak at Upcoming CDISC Interchange with Technology Partners

November 10, 2009

Almac Clinical Technologies, a leading provider of IVR/IWR technology, announced today that it will be speaking at the upcoming CDISC North American Interchange on a panel with alliance partners Medidata Solutions and PHT Corporation.

The panel will focus on data integration between best-in-class technology solutions, explaining how CDISC standards have been applied to allow multiple technologies to work with each other and promote interoperability. Details of the panel:

Presentation: “Standards-Based Approach to Creating One Elegant Multi-System Solution”

Speakers: Carl Labb, Almac Clinical Technologies; Joseph Dustin, Medidata Solutions; Scott Bradley, PHT

Parallel Track 1. Session 6A: ODM

Date & Time: Thursday, November 12, 10:30–12:30 p.m. EST

Jim Murphy, President of Almac Clinical Technologies, says

“Almac is committed to providing high quality, integrated data to our clients. Our partnerships with Medidata and PHT allow us to offer clients three leading technology systems, each backed by strong expertise.  We have worked with our partners to engineer the data integration across our multi-system solution up front in order to remove effort and time from the study set-up process.  The CDISC conference will allow the industry to view the promise of this data integration approach first-hand.”

Additionally, Almac, PHT and Medidata Solutions will co-host

“Get in Touch with Integrated Clinical Data,”

a booth tour to showcase rapid data sharing across three best-in-class systems using industry standards. Participants will be able to track a patient from randomization in Almac’s IXRS™ integrated Interactive Voice and Web Response System to electronic patient diary entries in the PHT LogPad® system, ending with CRF data entries in the Medidata Rave® electronic data capture, management and reporting system, where participants can view all previously entered data now available in one system. To witness first hand the benefits of integrated IVR/IWR, ePRO and EDC data, please visit booths 8, 9 and 10.

About CDISC Interchange North America

CDISC is a global, open, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata. The CDISC Interchanges strive to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. CDISC standards are vendor-neutral, platform-independent and freely available via the CDISC website. For more information, please visit

About Almac Clinical Technologies

Almac Clinical Technologies is a division of the Almac Group that specializes in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS™) for patient randomization, tracking and clinical supply management; electronic patient reported outcomes data collection; and Web drug reconciliation. Almac’s technologies have been deployed in over 1400 clinical trials, incorporating over 1.5 million patients in over 80 countries and more than 60 languages.



Meghan Adams

T: (001) 267-685-4284

E:[email protected]


About Almac Group:

The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, translational genomic services, API manufacture, formulation development, clinical trial supply and technology (IVRS & Web), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.

The company employs over 2,500 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Construction of the company’s new $120m North American Headquarters started in July 08 and is expected to be completed 2010. Almac was awarded Northern Ireland’s “Business of the Year” award in 2009.

For more information about the Almac Group, please visit or e-mail [email protected].

About Medidata Solutions Worldwide

Medidata Solutions ( is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers’ clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer®), investigator benchmarking and budgeting (Medidata Grants Manager™), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor™), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 400 clinical trials by 100 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad® Tablet deliver the voice of the patient, in 88 languages, from homes and sites in 65 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 12 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning


Back to news